Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

7 Biggest Lithium-mining Companies in 2024

Top 10 Oil-producing Countries (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

Hydrogen Stocks: 9 Biggest Companies in 2024

How to Invest in OpenAI's ChatGPT (Updated 2024)

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Where Does Tesla Get its Lithium? (Updated 2024)

Trending Press Releases

SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout

Altech – CERENERGY® First 60 KWh Prototype Online and Achieving Great Results

Glencore Loan Facility Closed, Offtakes Executed

SAGA Metals Engages Expert Geologist for Petrographic Analysis and Prepares for Second Tranche of IPO

Vertex Acquires Drill Rig to Advance Exploration, at the High-Grade Reward Gold Mine, Below the Existing Resource

More Press Releases
Trending Companies

Saga Metals

SAGA:CA

Element79 Gold Corp

ELEM:CC

Sociedad Quimica y Minera S.A. (SQM)

SQM:NYE

Black Swan Graphene

SWAN:CC
More Companies
Trending Reports

2024 Lithium Market Outlook

Silver Price Forecast - What Happened And Where Do We Go From Here?

2024 Energy Outlook Report

Rare Earths Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Sonnet BioTherapeutics Holdings Inc.

NASDAQ:SONN
Press Releases

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Interactive Chart

×